Activation of the MEK/ERK pathway mediates MM cell proliferation, survival and migration [128], and accumulation of RAS/RAF pathway aberrations is deeply involved in the progression, relapse and drug resistance in MM. The gene discussed is MAPK1; the disease is Miyoshi myopathy.